Letter by Isa Ardahanli Regarding Article, Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?

Affiliations

¹ Department of Cardiology, Seyh Edebali University School of Medicine, Bilecik, Turkiye.
² Department of Cardiology, Erzurum City Hospital, Erzurum, Turkiye.

Comment

Isa Ardahanli et al. J Lipid Atheroscler. 2025 Jan.

. 2025 Jan;14(1):128-129.

doi: 10.12997/jla.2025.14.1.128. Epub 2025 Jan 8.

¹ Department of Cardiology, Seyh Edebali University School of Medicine, Bilecik, Turkiye.
² Department of Cardiology, Erzurum City Hospital, Erzurum, Turkiye.

No abstract available

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare.

Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?
Patel R, Sharma JB, Rajput S. Patel R, et al. J Lipid Atheroscler. 2024 Jan;13(1):61-68. doi: 10.12997/jla.2024.13.1.61. Epub 2023 Oct 26. J Lipid Atheroscler. 2024. PMID: 38299164 Free PMC article.

1. Patel R, Sharma JB, Rajput S. Statins ticagrelor and rhabdomyolysis: a coincidence or a drug interaction? J Lipid Atheroscler. 2024;13:61–68. - PMC - PubMed
1. Ananthram MG, Gottlieb SS. Renal dysfunction and heart failure with preserved ejection fraction. Heart Fail Clin. 2021;17:357–367. - PubMed
1. Zhao L, Li S, Gao Y. Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2021;43:718–728. - PMC - PubMed
1. Patel J, Rassekh N, Fonarow GC, Deedwania P, Sheikh FH, Ahmed A, et al. Guideline-directed medical therapy for the treatment of heart failure with reduced ejection fraction. Drugs. 2023;83:747–759. - PubMed
1. Wang N, Woodward M, Huffman MD, Rodgers A. Compounding benefits of cholesterol-lowering therapy for the reduction of major cardiovascular events: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2022;15:e008552. - PubMed